Clinical Trial Update: Effect of Erythropoietin on Preterm Brain Injury [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating erythropoietin for preterm brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Birth

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Zhengzhou Children's Hospital, China | Conditions: Premature Birth | Phase 4 | Status: COMPLETED